AVN Logo

Study: SARS-CoV-2 Vaccination and Myocarditis

Share Post :

 

April 20, 2022: SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents

“Results of this large cohort study indicated that both first and second doses of mRNA vaccines were associated with increased risk of myocarditis and pericarditis.”

 

Conclusions from the study continued… ” For individuals receiving 2 doses of the same vaccine, risk of myocarditis was highest among young males (aged 16-24 years) after the second dose. These findings are compatible with between 4 and 7 excess events in 28 days per 100 000 vaccinees after BNT162b2, and between 9 and 28 excess events per 100 000 vaccinees after mRNA-1273. This risk should be balanced against the benefits of protecting against severe COVID-19 disease.”

With a survivability rate of 99.97%,  none of this ? need have occurred.

 

jamacardiology_karlstad_2022_oi_220012_1649705559.15066

Trending Post

Embarking on Your Vaccination Journey?

A very big warm welcome to all our new website visitors who are researching vaccination for the first time. The Covid situation has inspired a lot more people to start asking questions about all vaccinations.

Marilyn Shares Youngest Sister Affected by Jab and Dies

Marilyn speaks with Meryl on the VaxXed Bus about how her youngest sister was affected by the jab and sadly, later dies.

Kat Shares Vaccine Reaction Story with Meryl

Kat speaks with Meryl about her reactions following the receipt of both tetanus and MMR vaccines in the same day.

Francie Shares Her Stories in Beginning of COVID Outbreak

As a nurse, Francie recalls her experience on what happened at the start of COVID and vaccination campaigns.